,reactionmeddraversionpt,reactionmeddrapt,safetyreportid,reactionoutcome
0,21.1,Weight decreased,16047456,
1,21.1,Decreased appetite,16047456,
0,21.1,Dyspnoea,16047516,
1,21.1,Coronary artery occlusion,16047516,
2,21.1,Headache,16047516,
3,21.1,Arrhythmia,16047516,
0,21.1,Rash,16047703,
1,21.1,Throat irritation,16047703,
2,21.1,Wound,16047703,
0,21.1,Skin odour abnormal,16047972,
1,21.1,Feeling hot,16047972,
2,21.1,Drug interaction,16047972,
3,21.1,Abdominal pain upper,16047972,
0,21.1,Prostatic specific antigen increased,16051117,
0,21.1,Chills,16051321,
0,21.1,Pyrexia,16052441,
1,21.1,Pain,16052441,
2,21.1,Neuropathy peripheral,16052441,
0,21.1,Decreased appetite,16052535,
1,21.1,Chest pain,16052535,
2,21.1,Nausea,16052535,
0,21.1,Pain,16056395,
1,21.1,Paraesthesia,16056395,
2,21.1,Rash,16056395,
3,21.1,Thyroid operation,16056395,
4,21.1,Skin irritation,16056395,
0,21.1,Oedema peripheral,16056398,
1,21.1,Non-dipping,16056398,
0,21.1,Peripheral swelling,16056428,
0,21.1,Hot flush,16056705,
1,21.1,Chills,16056705,
2,21.1,Dyspnoea,16056705,
0,21.1,Muscle spasms,16056733,
0,21.1,Nausea,16056846,
1,21.1,Headache,16056846,
0,21.1,Hyperhidrosis,16057059,
1,21.1,Hot flush,16057059,
0,21.1,Muscular weakness,16059720,
1,21.1,Back pain,16059720,
0,21.1,Cystitis,16059869,
0,21.1,Abdominal discomfort,16060271,
1,21.1,Diarrhoea,16060271,
0,21.1,Diarrhoea,16060706,
1,21.1,Confusional state,16060706,
0,21.1,Neck pain,16060855,
1,21.1,Musculoskeletal pain,16060855,
0,21.1,Urinary tract infection,16060861,
1,21.1,Stomatitis,16060861,
0,21.1,Fatigue,16060895,
1,21.1,Hot flush,16060895,
2,21.1,Arthralgia,16060895,
0,21.1,Gastrooesophageal reflux disease,16061231,
0,21.1,Pyrexia,16061528,
0,21.1,Hospitalisation,16062122,
1,21.1,Therapy cessation,16062122,
0,21.1,Anaemia,16062228,
0,21.1,Back pain,16062291,
0,21.1,Treatment failure,16062520,
0,21.1,Hot flush,16062533,
1,21.1,Hypoaesthesia,16062533,
2,21.1,Nausea,16062533,
0,21.1,Mouth ulceration,16062544,
0,21.1,Localised infection,16062554,
1,21.1,Therapy cessation,16062554,
0,21.1,Nausea,16062717,
1,21.1,Jugular vein thrombosis,16062717,
0,21.1,Therapy cessation,16062845,
1,21.1,Palmar-plantar erythrodysaesthesia syndrome,16062845,
2,21.1,Insomnia,16062845,
3,21.1,Abdominal discomfort,16062845,
4,21.1,Fatigue,16062845,
5,21.1,Skin exfoliation,16062845,
6,21.1,Condition aggravated,16062845,
0,21.1,Pneumonia,16062848,
0,21.1,Death,16066146,
0,21.1,Ear discomfort,16066227,
1,21.1,Upper-airway cough syndrome,16066227,
2,21.1,Dry throat,16066227,
0,21.1,Post procedural complication,16066436,
1,21.1,Urinary tract obstruction,16066436,
0,21.1,Disease progression,16066452,
1,21.1,Therapy cessation,16066452,
0,21.1,Respiratory disorder,16067782,
1,21.1,Cardiac disorder,16067782,
2,21.1,Fatigue,16067782,
3,21.1,Arthropathy,16067782,
4,21.1,Diabetes mellitus,16067782,
5,21.1,Pain,16067782,
6,21.1,Testicular atrophy,16067782,
7,21.1,Hot flush,16067782,
0,21.1,Neuralgia,16071202,
1,21.1,Pain in extremity,16071202,
0,21.1,Onychomadesis,16071506,
1,21.1,Nail discolouration,16071506,
0,21.1,Hypophagia,16071658,
1,21.1,Nausea,16071658,
0,21.1,Pneumonitis,16071779,
1,21.1,Procedural complication,16071779,
2,21.1,Pain in extremity,16071779,
3,21.1,Inflammation,16071779,
0,21.1,Off label use,16071898,
0,21.1,Dizziness,16072028,
1,21.1,Disorientation,16072028,
2,21.1,Feeling abnormal,16072028,
0,21.1,Fatigue,16076540,
1,21.1,Nausea,16076540,
2,21.1,Vomiting,16076540,
0,21.1,Gastrointestinal disorder,16076625,
1,21.1,Weight decreased,16076625,
0,21.1,Pruritus,16076640,
1,21.1,Rash,16076640,
2,21.1,Myalgia,16076640,
3,21.1,Ulcerative keratitis,16076640,
0,21.1,Prostatic specific antigen increased,16076908,
1,21.1,Discontinued product administered,16076908,
0,21.1,Constipation,16076909,
0,21.1,Weight decreased,16077036,
1,21.1,Gastrointestinal disorder,16077036,
0,21.1,Hypoaesthesia,16077145,
0,21.1,Viral infection,16077225,
0,21.1,Arthropathy,16077238,
1,21.1,Hypoaesthesia,16077238,
0,21.1,Alveolitis allergic,16077242,
0,21.1,Acne,16077450,
1,21.1,Alopecia,16077450,
2,21.1,Diarrhoea,16077450,
3,21.1,Furuncle,16077450,
0,21.1,Therapy cessation,16077741,
1,21.1,Colon operation,16077741,
0,21.1,Death,16077922,
0,21.1,Dyspnoea,16078071,
0,21.1,Diarrhoea,16082913,
0,21.1,Pneumonitis,16083404,
0,21.1,Cystitis,16084494,
0,21.1,Status epilepticus,15964297,6
1,21.1,Hyperammonaemic encephalopathy,15964297,6
2,21.1,Pyrexia,15964297,6
3,21.1,Hypertension,15964297,6
4,21.1,Platelet count increased,15964297,6
5,21.1,Metabolic acidosis,15964297,6
6,21.1,White blood cell count increased,15964297,6
7,21.1,Hyperlactacidaemia,15964297,6
8,21.1,Hyperammonaemia,15964297,1
9,21.1,Coma,15964297,1
0,21.1,Hypertension,15964353,1
1,21.1,Hot flush,15964353,1
0,22.1,Dermatitis allergic,15964426,1
1,22.1,Neutropenia,15964426,1
2,22.1,Dyspepsia,15964426,1
3,22.1,Constipation,15964426,1
4,22.1,Fatigue,15964426,3
5,22.1,Nasopharyngitis,15964426,1
6,22.1,Electrocardiogram QT prolonged,15964426,1
7,22.1,Headache,15964426,3
8,22.1,Alopecia,15964426,3
0,22.0,Neutropenia,15964439,6
0,22.0,Death,15964465,5
1,22.0,Intestinal obstruction,15964465,6
0,21.1,Oligohydramnios,15964472,3
0,21.1,Malignant neoplasm progression,15964511,6
1,21.1,Metastases to bone,15964511,6
2,21.1,Product use in unapproved indication,15964511,6
3,21.1,Prostate cancer,15964511,6
0,21.1,Drug hypersensitivity,15964529,6
0,21.1,Urosepsis,15964562,1
0,22.0,Organ failure,15964571,5
1,22.0,Product use in unapproved indication,15964571,6
2,22.0,Syncope,15964571,6
0,21.1,Intentional product use issue,15964576,6
1,21.1,Death,15964576,5
2,21.1,Off label use,15964576,6
0,22.0,Maternal exposure during pregnancy,15964588,6
1,22.0,Oligohydramnios,15964588,3
0,21.1,Nausea,15964600,6
1,21.1,Vomiting,15964600,6
2,21.1,Acute kidney injury,15964600,3
0,21.1,Upper respiratory tract infection,15964657,3
0,21.1,Diarrhoea,15964665,1
1,21.1,Enterocolitis,15964665,1
2,21.1,Lung disorder,15964665,6
3,21.1,Anaemia,15964665,1
4,21.1,Malignant neoplasm progression,15964665,5
5,21.1,Arrhythmia,15964665,1
0,21.1,Fatigue,15964688,6
1,21.1,Cellulitis,15964688,6
0,21.1,Lipase increased,15964704,2
1,21.1,Amylase increased,15964704,2
0,21.1,Anaphylactic shock,15964749,1
0,21.1,Drug intolerance,15964752,6
0,22.0,Anaemia,15964755,1
1,22.0,Red blood cell abnormality,15964755,2
0,21.1,Adrenal neoplasm,15964784,3
1,21.1,Proctalgia,15964784,3
2,21.1,Bladder pain,15964784,3
3,21.1,Pain,15964784,3
4,21.1,Incorrect route of product administration,15964784,3
5,21.1,Abdominal pain,15964784,3
0,21.1,Acute coronary syndrome,15964824,1
0,21.1,Pyrexia,15964833,6
1,21.1,Abdominal pain,15964833,6
2,21.1,Cholecystitis acute,15964833,6
3,21.1,Thrombocytopenia,15964833,6
4,21.1,Vomiting,15964833,6
5,21.1,Neutropenia,15964833,6
0,21.1,Stomatitis,15964894,1
1,21.1,Diarrhoea,15964894,1
2,21.1,Asthenia,15964894,3
3,21.1,Vomiting,15964894,1
4,21.1,Respiratory tract infection,15964894,1
5,21.1,Neutropenia,15964894,1
0,21.1,Pancreatitis acute,15964910,5
0,21.1,Constipation,15964925,1
1,21.1,General physical health deterioration,15964925,2
0,21.1,Influenza,15964959,2
1,21.1,Constipation,15964959,2
2,21.1,Lip swelling,15964959,2
3,21.1,Bronchitis bacterial,15964959,2
4,21.1,Cough,15964959,2
5,21.1,Swollen tongue,15964959,2
6,21.1,Stomatitis,15964959,2
7,21.1,Dyspepsia,15964959,2
0,21.1,Weight decreased,15964961,6
0,21.1,Dysentery,15964966,1
1,21.1,Nausea,15964966,1
0,21.1,Vertigo,15964980,1
0,21.1,Tumour marker increased,15964981,6
1,21.1,Breast cancer metastatic,15964981,6
2,21.1,Blood pressure abnormal,15964981,1
3,21.1,Blood glucose abnormal,15964981,1
4,21.1,Pain,15964981,6
5,21.1,Blood creatinine abnormal,15964981,2
6,21.1,General physical health deterioration,15964981,1
7,21.1,Metastases to lung,15964981,6
8,21.1,Renal impairment,15964981,6
9,21.1,Metastases to bone,15964981,2
10,21.1,Metastases to liver,15964981,6
11,21.1,Malignant neoplasm progression,15964981,6
12,21.1,Skin toxicity,15964981,6
0,21.1,Alanine aminotransferase increased,15964984,1
1,21.1,Biliary dilatation,15964984,1
2,21.1,Amylase increased,15964984,1
3,21.1,Papilla of Vater stenosis,15964984,1
4,21.1,Cholelithiasis,15964984,1
5,21.1,Off label use,15964984,6
6,21.1,Cholestasis,15964984,1
7,21.1,Back pain,15964984,1
0,22.1,Rectal haemorrhage,15965010,3
1,22.1,Decreased appetite,15965010,3
2,22.1,Diarrhoea,15965010,1
3,22.1,Back pain,15965010,3
4,22.1,Cholelithiasis,15965010,3
5,22.1,Weight decreased,15965010,3
6,22.1,Rash pruritic,15965010,1
7,22.1,Diarrhoea,15965010,1
8,22.1,Hypomagnesaemia,15965010,1
9,22.1,Weight decreased,15965010,1
10,22.1,Acute kidney injury,15965010,1
11,22.1,Diarrhoea,15965010,1
12,22.1,Diarrhoea,15965010,1
13,22.1,Vomiting,15965010,1
0,22.0,Malignant neoplasm progression,15965033,5
0,22.0,Malignant neoplasm progression,15965089,5
0,21.1,Death,15965112,5
1,21.1,Pneumonia,15965112,6
2,21.1,Charles Bonnet syndrome,15965112,6
3,21.1,Dyspnoea,15965112,6
4,21.1,Blindness,15965112,3
5,21.1,Uveitis,15965112,3
6,21.1,Fatigue,15965112,6
7,21.1,Fall,15965112,6
8,21.1,Decreased activity,15965112,6
0,21.1,Abnormal behaviour,15965117,3
1,21.1,Disorientation,15965117,3
2,21.1,Memory impairment,15965117,3
3,21.1,Confusional state,15965117,3
0,21.1,Malaise,15965126,6
1,21.1,Pyrexia,15965126,6
2,21.1,Prostatic specific antigen increased,15965126,2
3,21.1,Asthenia,15965126,6
0,21.1,Febrile neutropenia,15965163,1
0,22.0,Cardiomegaly,15965182,6
1,22.0,Liver disorder,15965182,6
2,22.0,Immunodeficiency,15965182,1
3,22.0,Metastases to central nervous system,15965182,6
4,22.0,Haemoglobin decreased,15965182,6
5,22.0,Heart rate irregular,15965182,6
6,22.0,Intentional product use issue,15965182,6
7,22.0,Weight decreased,15965182,3
8,22.0,Off label use,15965182,6
9,22.0,Seizure,15965182,6
10,22.0,Disease recurrence,15965182,3
11,22.0,Platelet count decreased,15965182,1
12,22.0,Hypoaesthesia,15965182,3
13,22.0,White blood cell count decreased,15965182,6
14,22.0,Coagulopathy,15965182,1
0,22.0,Ejection fraction decreased,15965195,3
0,21.1,Nerve injury,15965228,6
1,21.1,Neuropathy peripheral,15965228,6
2,21.1,Ill-defined disorder,15965228,6
3,21.1,Herpes zoster,15965228,6
0,21.1,Rash,15965244,2
0,22.0,Colitis,15965261,3
1,22.0,Neuropathy peripheral,15965261,3
0,21.1,Mucosal inflammation,15965309,6
1,21.1,Peripheral sensory neuropathy,15965309,6
2,21.1,Dehydration,15965309,6
3,21.1,Toxicity to various agents,15965309,6
4,21.1,Diarrhoea,15965309,6
5,21.1,Haematotoxicity,15965309,6
6,21.1,Myocardial ischaemia,15965309,6
0,22.0,Respiratory failure,15965417,1
0,21.1,Dermatomyositis,15965426,2
0,22.0,Dermatitis bullous,15965445,1
0,22.1,Sepsis,15965456,2
1,22.1,Atrial tachycardia,15965456,1
0,22.0,Hypophysitis,15965619,1
0,22.0,Malignant neoplasm progression,15965633,5
1,22.0,Malignant pleural effusion,15965633,6
2,22.0,Interstitial lung disease,15965633,2
3,22.0,Rash,15965633,6
0,21.1,Fracture,15965657,2
1,21.1,Neutropenia,15965657,1
2,21.1,Rash,15965657,1
0,22.0,Death,15965673,5
1,22.0,Deafness,15965673,3
0,21.1,Death,15965690,5
0,21.1,Respiratory disorder,15965747,6
0,22.0,Lymphorrhoea,15965756,3
1,22.0,Ascites,15965756,3
0,21.1,General physical health deterioration,15965757,1
1,21.1,Diarrhoea,15965757,1
2,21.1,Pulpitis dental,15965757,1
3,21.1,Mucosal inflammation,15965757,1
4,21.1,Dyspnoea,15965757,1
5,21.1,Vomiting,15965757,1
6,21.1,Hypertension,15965757,2
7,21.1,Nausea,15965757,1
8,21.1,Weight decreased,15965757,1
9,21.1,Sensory disturbance,15965757,1
10,21.1,Tooth erosion,15965757,1
11,21.1,Periodontitis,15965757,3
12,21.1,Venous thrombosis limb,15965757,2
13,21.1,Dysphagia,15965757,1
14,21.1,Thrombosis,15965757,3
0,21.1,HER-2 positive breast cancer,15965759,6
0,22.1,Alopecia,15965799,2
0,22.0,Neoplasm progression,15965801,6
0,22.0,Full blood count decreased,15965845,3
1,22.0,Nausea,15965845,2
2,22.0,Anaemia,15965845,3
3,22.0,Hypoacusis,15965845,6
4,22.0,Fatigue,15965845,3
0,22.0,Neutropenia,15965848,6
0,21.1,Anxiety,15965862,6
1,21.1,Alopecia,15965862,3
2,21.1,Depression,15965862,6
3,21.1,Hair colour changes,15965862,3
4,21.1,Madarosis,15965862,3
5,21.1,Hair texture abnormal,15965862,3
6,21.1,Hair disorder,15965862,3
0,22.0,Madarosis,15965865,3
1,22.0,Alopecia,15965865,3
2,22.0,Hair disorder,15965865,3
3,22.0,Hair texture abnormal,15965865,3
4,22.0,Hair colour changes,15965865,3
0,22.1,Alopecia,15965877,3
1,22.1,Hair disorder,15965877,3
2,22.1,Hair texture abnormal,15965877,3
3,22.1,Madarosis,15965877,3
4,22.1,Hair colour changes,15965877,3
0,22.0,Alopecia,15965881,3
1,22.0,Hair texture abnormal,15965881,3
2,22.0,Madarosis,15965881,3
3,22.0,Hair disorder,15965881,3
4,22.0,Hair colour changes,15965881,3
0,21.1,Myocardial infarction,15965884,5
0,21.1,Blister,15965885,1
1,21.1,Neoplasm progression,15965885,1
0,21.1,Neoplasm progression,15965956,6
0,22.1,Nausea,15966016,1
1,22.1,Weight decreased,15966016,1
2,22.1,Hypocalcaemia,15966016,6
3,22.1,Dyspnoea,15966016,6
4,22.1,General physical health deterioration,15966016,5
5,22.1,Rash,15966016,3
6,22.1,Breast cancer metastatic,15966016,5
7,22.1,Confusional state,15966016,3
8,22.1,Constipation,15966016,1
9,22.1,Disorientation,15966016,3
10,22.1,Metastases to pleura,15966016,6
11,22.1,Malignant neoplasm progression,15966016,5
12,22.1,Diarrhoea,15966016,1
13,22.1,Vomiting,15966016,1
14,22.1,Pleural effusion,15966016,6
0,21.1,Malignant neoplasm progression,15966039,6
0,22.0,Haemorrhage urinary tract,15966050,3
1,22.0,Monoplegia,15966050,1
2,22.0,Cerebrovascular accident,15966050,1
3,22.0,Facial paralysis,15966050,1
0,21.1,Abdominal discomfort,15966085,6
1,21.1,Mood altered,15966085,6
2,21.1,Headache,15966085,6
3,21.1,Haemoglobin decreased,15966085,6
4,21.1,Hypertension,15966085,6
5,21.1,Feeling abnormal,15966085,2
6,21.1,Platelet disorder,15966085,6
7,21.1,Stomatitis,15966085,6
8,21.1,Product use in unapproved indication,15966085,6
9,21.1,Thrombosis,15966085,6
10,21.1,Malignant neoplasm progression,15966085,6
11,21.1,Blood chloride decreased,15966085,6
12,21.1,Back pain,15966085,3
13,21.1,Tearfulness,15966085,1
14,21.1,Weight decreased,15966085,6
15,21.1,Anxiety,15966085,6
16,21.1,Fatigue,15966085,6
17,21.1,Spinal pain,15966085,6
18,21.1,Blood potassium decreased,15966085,6
0,21.1,Subileus,15966134,6
1,21.1,Ascites,15966134,3
0,21.1,Rectal haemorrhage,15966157,5
1,21.1,Cardiac failure,15966157,5
2,21.1,Bleeding time abnormal,15966157,5
0,21.1,Intentional product use issue,15966170,6
1,21.1,Off label use,15966170,6
2,21.1,No adverse event,15966170,6
0,22.0,Epistaxis,15966196,6
1,22.0,Skin haemorrhage,15966196,6
2,22.0,Skin fissures,15966196,1
0,21.1,Injection site pain,15966258,6
1,21.1,Swelling face,15966258,6
2,21.1,Lethargy,15966258,6
3,21.1,Facial pain,15966258,6
4,21.1,Asthenia,15966258,3
5,21.1,Tumour marker increased,15966258,3
6,21.1,Blood alkaline phosphatase increased,15966258,1
7,21.1,Feeling hot,15966258,6
8,21.1,Appetite disorder,15966258,6
9,21.1,Memory impairment,15966258,3
10,21.1,Dental caries,15966258,3
11,21.1,Device breakage,15966258,6
12,21.1,Allergic sinusitis,15966258,3
13,21.1,Osteonecrosis of jaw,15966258,2
14,21.1,Feeling abnormal,15966258,6
0,22.1,Meningitis,15966270,1
0,21.1,Diarrhoea,15966280,6
1,21.1,Pneumonia,15966280,5
2,21.1,Metastasis,15966280,6
3,21.1,Haematochezia,15966280,6
0,22.0,Confusional state,15966359,6
1,22.0,Product dispensing issue,15966359,6
0,21.1,Malaise,15966364,6
1,21.1,Hypoacusis,15966364,6
2,21.1,Product use in unapproved indication,15966364,6
3,21.1,Speech disorder,15966364,6
0,22.1,White blood cell count decreased,15966496,2
1,22.1,Pneumonia,15966496,6
2,22.1,Blood disorder,15966496,6
3,22.1,Atypical pneumonia,15966496,1
4,22.1,Angiopathy,15966496,6
5,22.1,Blood count abnormal,15966496,6
6,22.1,Condition aggravated,15966496,3
7,22.1,Kidney infection,15966496,1
8,22.1,Cardiac failure congestive,15966496,6
9,22.1,Interstitial lung disease,15966496,3
10,22.1,Gastric haemorrhage,15966496,3
11,22.1,Red blood cell count decreased,15966496,3
12,22.1,Dependence on oxygen therapy,15966496,6
13,22.1,Stomach mass,15966496,6
0,21.1,Urticaria,15966563,6
1,21.1,Dermatitis contact,15966563,6
2,21.1,Abdominal neoplasm,15966563,6
3,21.1,Nausea,15966563,6
4,21.1,Drug intolerance,15966563,1
5,21.1,Appendicitis,15966563,6
6,21.1,Diarrhoea,15966563,6
7,21.1,Post procedural swelling,15966563,2
8,21.1,Breast reconstruction,15966563,2
9,21.1,Procedural pain,15966563,3
10,21.1,Drug hypersensitivity,15966563,6
0,22.0,Left ventricular failure,15966587,6
1,22.0,Prostate cancer metastatic,15966587,6
2,22.0,Therapeutic product effect decreased,15966587,6
0,22.0,Dementia,15966613,6
1,22.0,Impaired quality of life,15966613,6
2,22.0,Condition aggravated,15966613,6
0,21.1,Atrial flutter,15966633,6
0,21.1,Influenza,15966662,6
1,21.1,Metastases to bone,15966662,6
2,21.1,Death,15966662,5
0,21.1,Balance disorder,15966673,6
1,21.1,Cerebrovascular accident,15966673,4
0,21.1,Oesophageal food impaction,15966677,6
1,21.1,Hiatus hernia,15966677,6
2,21.1,Decreased appetite,15966677,6
3,21.1,Constipation,15966677,6
4,21.1,Prostate cancer metastatic,15966677,6
5,21.1,Nausea,15966677,6
6,21.1,Prostatic specific antigen increased,15966677,6
7,21.1,Weight decreased,15966677,6
0,21.1,Arthropathy,15966751,6
0,21.1,Pain,15966765,6
1,21.1,Insomnia,15966765,6
2,21.1,Malaise,15966765,6
0,21.1,Product dose omission,15966768,6
1,21.1,No adverse event,15966768,6
0,21.1,Rash,15966775,6
1,21.1,Stevens-Johnson syndrome,15966775,1
2,21.1,Pneumocystis jirovecii pneumonia,15966775,1
3,21.1,Cutaneous symptom,15966775,6
4,21.1,Dermatitis,15966775,1
0,21.1,Cyanosis,15966789,1
1,21.1,Malaise,15966789,1
0,21.1,Dementia,15966821,3
1,21.1,Alopecia,15966821,3
2,21.1,Ovarian cancer,15966821,6
3,21.1,Somnolence,15966821,2
4,21.1,Neoplasm,15966821,6
0,21.1,Acute leukaemia,15966842,6
1,21.1,Sepsis,15966842,5
0,21.1,Dysphagia,15966853,6
0,21.1,Lower respiratory tract infection,15966866,1
1,21.1,Nausea,15966866,1
0,21.1,Death,15966868,5
0,22.0,Road traffic accident,15966869,5
0,21.1,Haematotoxicity,15966870,5
0,21.1,Death,15966871,5
0,21.1,Pyrexia,15966887,6
1,21.1,Diarrhoea,15966887,6
0,22.1,Radiation pneumonitis,15966891,2
1,22.1,Pleural effusion,15966891,6
2,22.1,Diarrhoea,15966891,2
3,22.1,Colitis,15966891,6
4,22.1,Lung disorder,15966891,2
5,22.1,Interstitial lung disease,15966891,3
0,21.1,Skin odour abnormal,15966917,6
0,22.0,Gastritis,15966918,1
0,21.1,Hypersensitivity,15966929,1
1,21.1,Nausea,15966929,1
2,21.1,Erythema,15966929,1
3,21.1,Chest discomfort,15966929,1
0,22.0,Delirium,15967025,6
1,22.0,Diarrhoea,15967025,1
2,22.0,Aspiration,15967025,6
3,22.0,Thrombocytopenia,15967025,6
4,22.0,Therapeutic response decreased,15967025,6
5,22.0,Radial nerve palsy,15967025,6
6,22.0,Febrile neutropenia,15967025,1
7,22.0,Pneumonia,15967025,6
0,21.1,Acute promyelocytic leukaemia,15967040,5
0,21.1,Nipple pain,15967045,6
1,21.1,Peripheral swelling,15967045,3
2,21.1,Oral candidiasis,15967045,6
3,21.1,Fatigue,15967045,3
4,21.1,Lymphoedema,15967045,3
5,21.1,Blood pressure fluctuation,15967045,3
6,21.1,Toothache,15967045,6
7,21.1,Vulvovaginal candidiasis,15967045,6
8,21.1,Myalgia,15967045,6
9,21.1,Dry mouth,15967045,6
10,21.1,Tooth demineralisation,15967045,3
11,21.1,Osteoporosis,15967045,3
12,21.1,Tooth disorder,15967045,1
13,21.1,Pain in extremity,15967045,6
14,21.1,Hypertension,15967045,6
15,21.1,Eye pain,15967045,6
16,21.1,Diabetes mellitus,15967045,3
17,21.1,Sensory disturbance,15967045,3
18,21.1,Muscle spasms,15967045,3
19,21.1,Pain,15967045,3
20,21.1,Osteoarthritis,15967045,6
21,21.1,Tooth infection,15967045,6
22,21.1,Headache,15967045,6
23,21.1,Arthralgia,15967045,6
0,22.0,Facial paresis,15967066,2
1,22.0,Seizure,15967066,1
2,22.0,Weight decreased,15967066,6
3,22.0,Epilepsy,15967066,2
4,22.0,Gait disturbance,15967066,6
5,22.0,Cachexia,15967066,1
6,22.0,Speech disorder,15967066,6
7,22.0,Nausea,15967066,6
8,22.0,Drug ineffective,15967066,6
9,22.0,Metastases to lung,15967066,3
10,22.0,Thrombocytopenia,15967066,1
11,22.0,Metastases to central nervous system,15967066,1
12,22.0,Loss of consciousness,15967066,2
13,22.0,Muscular weakness,15967066,1
0,21.1,Abdominal discomfort,15967082,1
1,21.1,Bone marrow failure,15967082,2
2,21.1,Hair texture abnormal,15967082,1
3,21.1,Dyspnoea exertional,15967082,6
4,21.1,Anaemia,15967082,6
5,21.1,Chills,15967082,1
6,21.1,Thrombocytopenia,15967082,6
0,21.1,Proteinuria,15967085,3
1,21.1,Vomiting,15967085,3
2,21.1,Protein urine present,15967085,3
0,21.1,Disease progression,15967109,
0,21.1,Blood count abnormal,15967113,
0,21.1,Psychological trauma,15967118,6
1,21.1,Alopecia,15967118,2
0,21.1,Surgery,15967170,6
0,21.1,Anxiety,15967218,6
1,21.1,Emotional distress,15967218,6
2,21.1,Pain,15967218,6
3,21.1,Alopecia,15967218,3
4,21.1,Impaired quality of life,15967218,6
0,22.1,Pain,15967220,6
1,22.1,Anxiety,15967220,6
2,22.1,Alopecia,15967220,2
3,22.1,Emotional distress,15967220,6
4,22.1,Impaired quality of life,15967220,6
5,22.1,Psychological trauma,15967220,6
0,22.0,Psychological trauma,15967238,6
1,22.0,Alopecia,15967238,2
0,22.1,No adverse event,15967248,6
0,22.1,Impaired quality of life,15967252,6
1,22.1,Pain,15967252,6
2,22.1,Alopecia,15967252,2
3,22.1,Emotional distress,15967252,6
4,22.1,Anxiety,15967252,6
0,22.0,Alopecia,15967273,2
0,21.1,Psychological trauma,15967277,6
1,21.1,Alopecia,15967277,2
0,21.1,Alopecia,15967295,3
1,21.1,Psychological trauma,15967295,6
0,21.1,Alopecia,15967307,2
1,21.1,Psychological trauma,15967307,6
0,21.1,Neutropenia,15967321,
0,21.1,Disease progression,15967323,
0,21.1,Disease progression,15967328,
0,22.1,Psychological trauma,15967329,6
1,22.1,Alopecia,15967329,2
0,21.1,Therapy cessation,15967392,
1,21.1,Product substitution issue,15967392,
2,21.1,Bipolar I disorder,15967392,
0,21.1,Cytopenia,15967397,
0,22.0,Alopecia,15967402,2
1,22.0,Psychological trauma,15967402,6
0,21.1,Disease progression,15967403,
0,22.0,Stomatitis,15967435,6
1,22.0,Bone marrow failure,15967435,6
2,22.0,Fatigue,15967435,3
3,22.0,White blood cell count decreased,15967435,2
4,22.0,Mucosal inflammation,15967435,6
5,22.0,Tumour marker increased,15967435,3
0,22.0,Epistaxis,15967436,6
1,22.0,Vomiting,15967436,6
2,22.0,Bone marrow failure,15967436,6
3,22.0,Stomatitis,15967436,2
4,22.0,Dry skin,15967436,2
5,22.0,Erythema,15967436,6
6,22.0,Nasal dryness,15967436,6
7,22.0,Upper limb fracture,15967436,6
8,22.0,Herpes zoster,15967436,1
0,22.0,Nausea,15967437,2
1,22.0,Fatigue,15967437,3
2,22.0,Neutropenia,15967437,6
3,22.0,Vomiting,15967437,6
4,22.0,Dehydration,15967437,6
5,22.0,Dizziness,15967437,6
6,22.0,Diarrhoea,15967437,6
7,22.0,Decreased appetite,15967437,3
8,22.0,Procedural pain,15967437,6
9,22.0,Transient ischaemic attack,15967437,6
10,22.0,Weight decreased,15967437,6
11,22.0,Constipation,15967437,6
12,22.0,Neoplasm progression,15967437,6
13,22.0,Death,15967437,5
14,22.0,Pneumonia,15967437,6
15,22.0,Orthostatic hypotension,15967437,6
16,22.0,Anaemia,15967437,6
17,22.0,Alopecia,15967437,3
18,22.0,Arthralgia,15967437,2
19,22.0,Leukopenia,15967437,6
0,21.1,Off label use,15967461,6
1,21.1,Chest pain,15967461,2
2,21.1,Back pain,15967461,2
3,21.1,Diarrhoea,15967461,1
0,21.1,Therapy cessation,15967505,
1,21.1,Sepsis,15967505,
0,21.1,Proteinuria,15967673,6
0,22.1,Cystitis,15967734,1
1,22.1,Gout,15967734,3
2,22.1,Impaired healing,15967734,1
3,22.1,Diarrhoea,15967734,1
4,22.1,Neutropenia,15967734,1
5,22.1,Malaise,15967734,1
6,22.1,Weight decreased,15967734,1
7,22.1,Post procedural fistula,15967734,1
8,22.1,Cardiac failure,15967734,3
9,22.1,Vertigo,15967734,3
10,22.1,Bronchitis,15967734,1
11,22.1,Hypertension,15967734,3
12,22.1,Dyspnoea,15967734,1
13,22.1,General physical health deterioration,15967734,1
14,22.1,Oral candidiasis,15967734,1
15,22.1,Decreased appetite,15967734,1
16,22.1,Atrial fibrillation,15967734,1
17,22.1,Fatigue,15967734,1
18,22.1,Leukocytosis,15967734,3
19,22.1,Constipation,15967734,1
20,22.1,Vomiting,15967734,1
0,21.1,Atrial flutter,15967782,6
1,21.1,Product use in unapproved indication,15967782,6
2,21.1,Off label use,15967782,6
0,21.1,Product use in unapproved indication,15967786,6
1,21.1,Cardiogenic shock,15967786,5
2,21.1,Off label use,15967786,6
0,21.1,Paraesthesia,15967803,3
0,22.0,Interstitial lung disease,15967812,3
1,22.0,Malignant neoplasm progression,15967812,5
2,22.0,Hepatic rupture,15967812,5
3,22.0,Dyspnoea exertional,15967812,6
4,22.0,Intra-abdominal haemorrhage,15967812,6
5,22.0,Hypothyroidism,15967812,3
6,22.0,Malaise,15967812,6
7,22.0,Abdominal pain upper,15967812,6
8,22.0,Hyperuricaemia,15967812,3
0,22.0,Liver function test increased,15967819,1
0,21.1,Lower respiratory tract infection,15967844,5
1,21.1,Rash,15967844,1
2,21.1,Diarrhoea,15967844,1
3,21.1,Pyrexia,15967844,1
4,21.1,Malignant neoplasm progression,15967844,6
0,21.1,Nausea,15967857,
1,21.1,Fatigue,15967857,
0,21.1,Drug intolerance,15967880,
0,22.1,Metastases to lymph nodes,15967922,6
1,22.1,Cardiomegaly,15967922,6
2,22.1,Cardiac failure congestive,15967922,5
3,22.1,Metastases to heart,15967922,6
4,22.1,Pericardial effusion,15967922,6
5,22.1,Lymphangiosis carcinomatosa,15967922,6
0,21.1,Death,15967943,
0,21.1,Hospice care,15967948,
0,21.1,Blood pressure increased,15967950,
0,21.1,Confusional state,15967951,
1,21.1,Hypotension,15967951,
0,22.0,Neutropenia,15967981,1
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,15967981,1
2,22.0,Mucosal inflammation,15967981,1
0,21.1,Gamma-glutamyltransferase increased,15968006,1
0,21.1,Tumour lysis syndrome,15968024,2
0,21.1,Osteonecrosis,15968055,6
0,21.1,Cardiac tamponade,15968071,3
0,22.0,Pruritus,15968074,2
1,22.0,Inappropriate schedule of product administration,15968074,6
2,22.0,Hypersensitivity,15968074,2
3,22.0,Prescribed overdose,15968074,3
4,22.0,Peripheral swelling,15968074,3
5,22.0,Urticaria,15968074,6
6,22.0,Pain in extremity,15968074,6
7,22.0,Memory impairment,15968074,3
8,22.0,Skin exfoliation,15968074,6
9,22.0,Skin disorder,15968074,2
10,22.0,Drug ineffective,15968074,6
0,21.1,Loss of consciousness,15968081,6
1,21.1,Burns third degree,15968081,6
2,21.1,Depression,15968081,3
0,21.1,Hyperkalaemia,15968169,2
1,21.1,Hyponatraemia,15968169,2
2,21.1,Vomiting,15968169,1
0,21.1,Fall,15968172,2
1,21.1,Vertigo,15968172,2
2,21.1,Asthenia,15968172,2
0,21.1,Dyspnoea,15968173,6
1,21.1,Hypoxia,15968173,6
0,21.1,Myocardial infarction,15968230,6
1,21.1,Dyspnoea,15968230,6
2,21.1,Neoplasm progression,15968230,6
0,21.1,Post procedural infection,15968236,1
1,21.1,Small intestinal perforation,15968236,6
2,21.1,Superinfection,15968236,1
0,21.1,Pancreatic carcinoma,15968378,3
0,21.1,Nausea,15968379,1
1,21.1,Heart rate increased,15968379,3
2,21.1,Oropharyngeal pain,15968379,3
3,21.1,Memory impairment,15968379,6
4,21.1,Fatigue,15968379,3
5,21.1,Diarrhoea,15968379,3
6,21.1,Dysphagia,15968379,2
7,21.1,Stomatitis,15968379,1
8,21.1,Pneumonia escherichia,15968379,6
9,21.1,Influenza like illness,15968379,1
10,21.1,Odynophagia,15968379,6
11,21.1,Asthenia,15968379,6
12,21.1,Escherichia sepsis,15968379,6
0,21.1,Rash,15968383,3
1,21.1,Febrile neutropenia,15968383,1
0,22.0,Gastric ulcer,15968450,6
0,21.1,Malignant neoplasm progression,15968479,5
0,22.0,Cerebrovascular accident,15968596,5
1,22.0,Ischaemic cerebral infarction,15968596,5
2,22.0,Cerebral haemorrhage,15968596,5
3,22.0,Paraneoplastic syndrome,15968596,5
0,21.1,Thrombocytopenia,15968617,6
0,21.1,Haemorrhage,15968643,3
1,21.1,Blood pressure increased,15968643,3
2,21.1,Pain,15968643,3
0,21.1,Malignant neoplasm progression,15968662,5
1,21.1,Diarrhoea,15968662,1
2,21.1,Blood creatinine increased,15968662,1
3,21.1,Non-small cell lung cancer,15968662,5
0,21.1,Death,15968676,5
0,21.1,Cerebrovascular accident,15968677,6
0,21.1,Pruritus,15968718,6
1,21.1,Product use issue,15968718,6
2,21.1,Dyspnoea,15968718,6
3,21.1,Flushing,15968718,6
4,21.1,Nausea,15968718,6
0,21.1,Transient ischaemic attack,15968719,6
0,21.1,Obstructive airways disorder,15968720,1
1,21.1,Urticaria,15968720,1
2,21.1,Vomiting,15968720,1
3,21.1,Flushing,15968720,1
4,21.1,Nausea,15968720,1
5,21.1,Pruritus,15968720,1
0,21.1,Hypomagnesaemia,15968724,1
1,21.1,Hypermagnesaemia,15968724,1
0,22.0,Malignant neoplasm progression,15968779,5
0,21.1,Chills,15968797,1
1,21.1,Diarrhoea,15968797,1
2,21.1,Vomiting,15968797,1
3,21.1,Dyspnoea,15968797,1
4,21.1,Flushing,15968797,1
5,21.1,Tachypnoea,15968797,1
6,21.1,Nausea,15968797,1
0,21.1,Large intestine perforation,15968813,1
0,21.1,Death,15968823,5
0,21.1,Carcinoembryonic antigen increased,15968911,6
1,21.1,Carbohydrate antigen 27.29 increased,15968911,6
0,21.1,Decreased appetite,15968928,2
1,21.1,Gastrointestinal disorder,15968928,1
2,21.1,Lung disorder,15968928,1
3,21.1,Weight decreased,15968928,2
0,22.1,Urticaria,15968935,3
1,22.1,Death,15968935,5
2,22.1,Dehydration,15968935,6
3,22.1,Blood count abnormal,15968935,6
4,22.1,White blood cell count decreased,15968935,3
0,21.1,Cardiac failure congestive,15968947,6
1,21.1,Product dose omission,15968947,6
2,21.1,Acute coronary syndrome,15968947,6
3,21.1,Respiratory disorder,15968947,6
0,21.1,Death,15968948,5
0,21.1,Pleural effusion,15968955,6
0,21.1,Purpura,15968958,1
0,21.1,Interstitial lung disease,15968961,6
0,21.1,Haemolytic uraemic syndrome,15968972,5
1,21.1,Cardiac arrest,15968972,5
0,21.1,Asthenia,15969034,1
1,21.1,Decreased appetite,15969034,1
2,21.1,Full blood count decreased,15969034,6
3,21.1,Nausea,15969034,1
0,21.1,Renal failure,15969107,6
1,21.1,Hypertension,15969107,1
2,21.1,Bacteraemia,15969107,1
3,21.1,Haemolytic uraemic syndrome,15969107,1
4,21.1,Microangiopathic haemolytic anaemia,15969107,6
5,21.1,Hepatic enzyme increased,15969107,6
0,21.1,Prescription drug used without a prescription,15969117,6
1,21.1,Therapeutic response unexpected,15969117,6
0,22.0,Acute kidney injury,15969128,1
1,22.0,Renal function test abnormal,15969128,1
2,22.0,Anti-neutrophil cytoplasmic antibody positive vasculitis,15969128,6
0,22.0,Condition aggravated,15969147,1
1,22.0,Anal fistula,15969147,1
2,22.0,Anal fissure,15969147,1
0,22.1,Prostate cancer metastatic,15969152,
0,21.1,Hyperglycaemia,15969153,6
0,22.0,Acute kidney injury,15969175,2
1,22.0,Diarrhoea,15969175,1
0,21.1,Renal impairment,15969189,3
0,21.1,Hypophosphataemia,15969220,6
0,21.1,Constipation,15969278,3
1,21.1,Off label use,15969278,6
0,21.1,Unevaluable event,15969303,6
0,21.1,Haemorrhage,15969304,6
0,22.0,Hypophagia,15969309,6
1,22.0,Malignant neoplasm progression,15969309,5
2,22.0,Dehydration,15969309,6
0,21.1,Hyperpyrexia,15969316,1
0,21.1,Pruritus,15969322,3
1,21.1,Urinary tract infection,15969322,3
2,21.1,Nausea,15969322,3
3,21.1,Hyperhidrosis,15969322,3
4,21.1,Hot flush,15969322,3
5,21.1,Asthenia,15969322,3
6,21.1,Headache,15969322,3
7,21.1,Trigger finger,15969322,1
8,21.1,Anxiety,15969322,3
9,21.1,Weight decreased,15969322,3
10,21.1,Insomnia,15969322,3
11,21.1,Mucosal dryness,15969322,3
12,21.1,Irritability,15969322,3
13,21.1,Gamma-glutamyltransferase increased,15969322,3
14,21.1,Arthralgia,15969322,3
0,21.1,Death,15969362,5
0,22.0,Ileus,15969404,1
1,22.0,Colitis,15969404,1
2,22.0,Dehydration,15969404,1
3,22.0,Urinary tract infection,15969404,1
0,21.1,Hair disorder,15969474,3
1,21.1,Hair colour changes,15969474,3
2,21.1,Alopecia,15969474,3
3,21.1,Hair texture abnormal,15969474,3
0,22.1,Alopecia,15969490,2
1,22.1,Pneumonia,15969490,6
0,22.0,Madarosis,15969493,3
1,22.0,Hair colour changes,15969493,3
2,22.0,Hair disorder,15969493,3
3,22.0,Mental impairment,15969493,6
4,22.0,Alopecia,15969493,3
5,22.0,Emotional disorder,15969493,6
6,22.0,Hair texture abnormal,15969493,3
0,21.1,White blood cell count decreased,15969497,6
1,21.1,Nausea,15969497,6
2,21.1,Pyrexia,15969497,6
0,21.1,Alopecia,15969503,3
1,21.1,Hair disorder,15969503,3
2,21.1,Madarosis,15969503,3
3,21.1,Hair texture abnormal,15969503,3
4,21.1,Hair colour changes,15969503,3
0,21.1,Metastasis,15969523,6
1,21.1,Breast cancer metastatic,15969523,6
2,21.1,Malignant neoplasm progression,15969523,6
3,21.1,Tumour marker increased,15969523,6
0,21.1,Sneezing,15969540,1
1,21.1,Hypoaesthesia,15969540,1
2,21.1,Pruritus,15969540,1
3,21.1,Nasal congestion,15969540,1
0,21.1,Vomiting,15969548,3
1,21.1,Immune system disorder,15969548,2
2,21.1,Ear discomfort,15969548,1
3,21.1,Product taste abnormal,15969548,3
4,21.1,Influenza,15969548,2
5,21.1,Product use complaint,15969548,3
0,21.1,Adrenal insufficiency,15969563,6
1,21.1,Adrenocorticotropic hormone deficiency,15969563,2
0,22.0,Liver disorder,15969653,6
1,22.0,Constipation,15969653,6
2,22.0,Interstitial lung disease,15969653,2
0,21.1,Pneumonia,15969733,1
1,21.1,Pulmonary embolism,15969733,1
0,21.1,Lung infection,15969948,5
0,21.1,Rash,15969980,2
0,21.1,Drug ineffective,15970179,6
1,21.1,Condition aggravated,15970179,3
2,21.1,Metastases to bone,15970179,3
0,21.1,Erythema,15971242,1
1,21.1,Infusion related reaction,15971242,
2,21.1,Dyspnoea,15971242,1
0,21.1,Aplasia,15971250,3
1,21.1,Anaemia,15971250,3
2,21.1,Thrombocytopenia,15971250,3
3,21.1,Febrile neutropenia,15971250,1
4,21.1,Febrile neutropenia,15971250,1
5,21.1,Pneumonia,15971250,3
6,21.1,Cytomegalovirus infection,15971250,3
7,21.1,Aplasia,15971250,3
8,21.1,Urinary tract infection,15971250,1
0,21.1,Interstitial lung disease,15971262,5
1,21.1,Pulmonary fibrosis,15971262,5
0,21.1,Dysuria,15971264,1
1,21.1,Hypokalaemia,15971264,1
2,21.1,Diarrhoea,15971264,1
3,21.1,Pneumonitis,15971264,3
4,21.1,Hypocalcaemia,15971264,1
5,21.1,Dysgeusia,15971264,1
6,21.1,Oedema peripheral,15971264,3
7,21.1,Abdominal pain,15971264,1
8,21.1,Hyperglycaemia,15971264,1
9,21.1,Dehydration,15971264,1
10,21.1,Vomiting,15971264,1
11,21.1,Nail disorder,15971264,3
0,22.0,Inappropriate schedule of product administration,15971269,6
1,22.0,Blindness,15971269,3
2,22.0,Metastases to lung,15971269,6
0,21.1,Limb injury,15971284,1
1,21.1,Pulmonary oedema,15971284,2
2,21.1,Pain,15971284,1
0,21.1,Fatigue,15971293,3
1,21.1,Sudden death,15971293,5
2,21.1,Neutropenia,15971293,1
0,22.0,Hot flush,15971411,3
1,22.0,Prostatic specific antigen increased,15971411,1
2,22.0,Cough,15971411,3
0,21.1,Therapy cessation,15971414,6
0,21.1,Death,15972441,5
0,21.1,Death,15972442,5
0,21.1,Death,15972447,5
0,22.1,Blood pressure increased,15972456,6
1,22.1,Prostatic specific antigen increased,15972456,1
2,22.1,Knee operation,15972456,6
3,22.1,Hip arthroplasty,15972456,6
4,22.1,Hot flush,15972456,2
5,22.1,Sinusitis,15972456,6
0,21.1,Death,15972468,5
0,21.1,Fatigue,15972497,6
1,21.1,Epistaxis,15972497,6
2,21.1,Appetite disorder,15972497,6
3,21.1,Depression,15972497,6
4,21.1,Stomatitis,15972497,6
5,21.1,Headache,15972497,6
6,21.1,Hypertrophy of tongue papillae,15972497,6
7,21.1,Asthenia,15972497,6
0,21.1,Death,15972499,5
0,22.0,Drug ineffective,15972519,6
1,22.0,Product quality issue,15972519,6
0,21.1,Aphthous ulcer,15972553,6
1,21.1,Dizziness,15972553,6
2,21.1,Malaise,15972553,6
3,21.1,White blood cell count decreased,15972553,6
4,21.1,Feeding disorder,15972553,6
5,21.1,Polyneuropathy,15972553,6
6,21.1,Stomatitis,15972553,6
7,21.1,Decreased appetite,15972553,6
8,21.1,Rhinorrhoea,15972553,6
9,21.1,Dysphagia,15972553,6
10,21.1,Dyspnoea,15972553,6
11,21.1,Drug ineffective,15972553,6
12,21.1,Platelet count decreased,15972553,6
13,21.1,Oropharyngeal pain,15972553,6
14,21.1,Neutrophil count abnormal,15972553,6
15,21.1,Headache,15972553,6
16,21.1,Skin disorder,15972553,6
17,21.1,Hypoaesthesia,15972553,6
18,21.1,Urinary tract infection,15972553,6
0,21.1,Neutropenia,15972555,1
1,21.1,Diarrhoea,15972555,1
2,21.1,Pulmonary embolism,15972555,1
3,21.1,Anaemia,15972555,1
4,21.1,Malignant neoplasm progression,15972555,5
0,21.1,Diarrhoea,15972556,1
1,21.1,Abdominal pain upper,15972556,5
2,21.1,Vomiting,15972556,1
3,21.1,Anaemia,15972556,1
4,21.1,Malignant neoplasm progression,15972556,5
0,21.1,Pruritus,15972566,1
1,21.1,Face oedema,15972566,1
2,21.1,Rash,15972566,1
0,21.1,Neuropathy peripheral,15972576,6
0,21.1,Neutropenia,15972578,5
1,21.1,Sepsis,15972578,5
0,21.1,Cardiac death,15972579,5
0,21.1,Drug ineffective,15972628,6
0,21.1,Febrile neutropenia,15972631,1
1,21.1,Colony stimulating factor therapy,15972631,6
2,21.1,White blood cell count increased,15972631,1
0,21.1,Metastases to pleura,15972644,5
1,21.1,Pneumonia,15972644,1
2,21.1,Pulmonary embolism,15972644,5
3,21.1,Atrial fibrillation,15972644,5
4,21.1,Urinary tract infection,15972644,1
5,21.1,Thrombosis,15972644,5
6,21.1,Left ventricular dysfunction,15972644,5
7,21.1,Malignant neoplasm progression,15972644,5
8,21.1,Pleural effusion,15972644,5
0,21.1,Metastases to bone,15972648,6
1,21.1,Prostatic specific antigen increased,15972648,6
2,21.1,Bone pain,15972648,6
3,21.1,Metastases to lymph nodes,15972648,6
4,21.1,Femur fracture,15972648,6
5,21.1,Major depression,15972648,6
6,21.1,Death,15972648,5
0,21.1,Death,15972682,5
1,21.1,Fatigue,15972682,6
2,21.1,Bone pain,15972682,6
3,21.1,Lung infection,15972682,6
0,21.1,Diarrhoea,15972688,2
1,21.1,Pneumonia,15972688,3
0,22.1,Off label use,15972699,6
1,22.1,Tooth extraction,15972699,6
2,22.1,Osteonecrosis of jaw,15972699,3
0,21.1,Constipation,15972706,6
0,22.0,Hypotension,15973287,1
1,22.0,Oxygen saturation decreased,15973287,1
2,22.0,Vertigo,15973287,1
3,22.0,Hyperhidrosis,15973287,1
0,21.1,Infusion related reaction,15973623,1
0,21.1,Drug intolerance,15973753,6
1,21.1,Drug ineffective,15973753,6
2,21.1,Constipation,15973753,6
0,21.1,Metastases to stomach,15973866,6
1,21.1,Breast cancer recurrent,15973866,6
2,21.1,Malignant neoplasm progression,15973866,6
0,22.0,Death,15973965,5
0,21.1,Pyrexia,15974009,1
1,21.1,Alanine aminotransferase increased,15974009,3
2,21.1,Aspartate aminotransferase increased,15974009,3
0,21.1,Malignant neoplasm progression,15974020,5
1,21.1,Blood lactate dehydrogenase increased,15974020,3
2,21.1,Blood creatinine decreased,15974020,3
3,21.1,Haemoglobin decreased,15974020,3
4,21.1,Pericardial effusion,15974020,6
0,21.1,Drug specific antibody,15974071,6
1,21.1,Thrombocytopenia,15974071,6
2,21.1,Coombs positive haemolytic anaemia,15974071,6
3,21.1,Coombs indirect test positive,15974071,6
0,22.0,Nausea,15974106,3
1,22.0,Injection site bruising,15974106,1
2,22.0,Injection site rash,15974106,1
3,22.0,Bone pain,15974106,3
4,22.0,Peptic ulcer,15974106,3
5,22.0,Vomiting,15974106,3
6,22.0,Hepatitis C,15974106,3
7,22.0,Visual impairment,15974106,1
8,22.0,Osteoporosis,15974106,3
9,22.0,Intestinal cyst,15974106,1
10,22.0,Haematochezia,15974106,3
11,22.0,Visual impairment,15974106,3
12,22.0,Injection site papule,15974106,1
13,22.0,Large intestine polyp,15974106,1
14,22.0,Dizziness,15974106,3
15,22.0,Gastrooesophageal reflux disease,15974106,3
16,22.0,Headache,15974106,3
17,22.0,Colon cancer,15974106,1
18,22.0,Medication error,15974106,3
0,21.1,Product use in unapproved indication,15974162,6
1,21.1,DNA mismatch repair protein gene mutation,15974162,6
0,22.1,Intentional product use issue,15974174,6
1,22.1,Metastases to skin,15974174,6
0,21.1,Metastases to bone,15974332,6
1,21.1,Breast cancer metastatic,15974332,6
2,21.1,Malignant neoplasm progression,15974332,6
3,21.1,Intestinal metastasis,15974332,6
0,21.1,Metastases to bone,15974343,6
0,21.1,Colitis,15974348,1
0,21.1,Cholestasis,15974408,2
0,21.1,Thyroid cancer,15974414,1
1,21.1,Dysphagia,15974414,6
2,21.1,Product size issue,15974414,6
0,21.1,Supraventricular tachycardia,15974421,1
1,21.1,Electrocardiogram ST segment elevation,15974421,6
2,21.1,Troponin increased,15974421,1
3,21.1,Hepatitis,15974421,1
4,21.1,Bronchitis,15974421,1
5,21.1,Gastritis,15974421,1
6,21.1,Metastases to bone,15974421,6
7,21.1,Fibrin D dimer increased,15974421,2
8,21.1,White blood cell count increased,15974421,6
0,21.1,Respiratory failure,15974446,5
1,21.1,Interstitial lung disease,15974446,5
2,21.1,Adenosquamous cell lung cancer,15974446,5
0,21.1,Product use in unapproved indication,15974494,6
1,21.1,Neutropenia,15974494,6
2,21.1,Carbohydrate antigen 125 increased,15974494,6
3,21.1,Off label use,15974494,6
4,21.1,Thrombosis,15974494,3
0,21.1,Muscular weakness,15974536,6
1,21.1,Muscular weakness,15974536,1
0,21.1,Sepsis,15974537,3
1,21.1,Bacteroides infection,15974537,1
2,21.1,Dehydration,15974537,1
3,21.1,Encephalopathy,15974537,1
4,21.1,Death,15974537,5
0,21.1,Lymphadenectomy,15974540,6
1,21.1,Abdominal operation,15974540,6
2,21.1,Epistaxis,15974540,1
3,21.1,Dyspnoea,15974540,1
4,21.1,Omentectomy,15974540,6
5,21.1,Pelvic operation,15974540,6
6,21.1,Peritoneal neoplasm,15974540,6
7,21.1,Blood pressure increased,15974540,1
8,21.1,Hysterectomy,15974540,6
9,21.1,Drug ineffective,15974540,6
10,21.1,Headache,15974540,1
0,22.1,Diarrhoea,15974560,6
1,22.1,Tumour necrosis,15974560,1
2,22.1,Weight decreased,15974560,2
3,22.1,Erythema,15974560,6
4,22.1,Breath sounds abnormal,15974560,6
5,22.1,Oedema peripheral,15974560,6
6,22.1,Glaucoma,15974560,3
0,22.0,Hypercalcaemia,15974570,1
0,22.0,Malignant neoplasm progression,15974582,5
1,22.0,Decubitus ulcer,15974582,3
0,21.1,Cardiotoxicity,15974588,2
1,21.1,Dyspepsia,15974588,2
2,21.1,Nausea,15974588,2
3,21.1,Chest discomfort,15974588,2
0,22.1,Gamma-glutamyltransferase increased,15974609,6
1,22.1,Metastases to adrenals,15974609,3
2,22.1,Pruritus,15974609,6
3,22.1,Intentional product use issue,15974609,6
4,22.1,Metastases to liver,15974609,6
5,22.1,Aspartate aminotransferase increased,15974609,6
6,22.1,Blood lactate dehydrogenase increased,15974609,6
7,22.1,Blood alkaline phosphatase increased,15974609,6
8,22.1,Nausea,15974609,6
9,22.1,Anaemia,15974609,1
10,22.1,Hypoaesthesia,15974609,6
11,22.1,Malignant neoplasm progression,15974609,5
0,21.1,Erythema,15974627,1
1,21.1,Hypertension,15974627,1
2,21.1,Oxygen saturation decreased,15974627,1
3,21.1,Face oedema,15974627,1
0,21.1,Procedural haemorrhage,15974677,6
1,21.1,Pleural effusion,15974677,6
2,21.1,Procedural complication,15974677,6
3,21.1,Hepatic failure,15974677,6
4,21.1,Ascites,15974677,6
0,21.1,Lower limb fracture,15974685,6
1,21.1,Fall,15974685,6
0,22.0,Rhabdomyolysis,15974747,3
1,22.0,Rhabdomyolysis,15974747,4
2,22.0,Cytomegalovirus infection,15974747,3
3,22.0,Dermatomyositis,15974747,4
4,22.0,Pseudomembranous colitis,15974747,3
5,22.0,Fungal infection,15974747,3
6,22.0,Disseminated intravascular coagulation,15974747,6
7,22.0,Shock,15974747,4
8,22.0,Psoas abscess,15974747,3
9,22.0,Pseudomembranous colitis,15974747,5
10,22.0,Muscular weakness,15974747,3
0,21.1,Thrombocytopenia,15974768,1
0,21.1,Dizziness,15974771,3
1,21.1,Underdose,15974771,6
2,21.1,Atrial fibrillation,15974771,6
3,21.1,Fatigue,15974771,3
0,21.1,Depressed level of consciousness,15974791,6
1,21.1,Gingival bleeding,15974791,3
2,21.1,Platelet count decreased,15974791,6
3,21.1,Pyrexia,15974791,1
4,21.1,Metastases to bone,15974791,6
5,21.1,Disease progression,15974791,5
6,21.1,Venous thrombosis,15974791,6
0,21.1,Haemorrhagic stroke,15974814,1
0,21.1,Malignant neoplasm progression,15974818,5
0,21.1,Post procedural haemorrhage,15974827,6
1,21.1,Small intestinal obstruction,15974827,6
2,21.1,Abdominal abscess,15974827,6
3,21.1,Liver abscess,15974827,6
4,21.1,Hypertension,15974827,6
5,21.1,Biliary fistula,15974827,6
0,21.1,Respiratory failure,15974836,5
0,21.1,Death,15974837,5
0,21.1,Skin toxicity,15974839,6
0,21.1,Hypertension,15974869,6
1,21.1,Electrocardiogram QT prolonged,15974869,6
0,22.0,Malignant neoplasm progression,15974879,5
0,21.1,Tooth abscess,15974929,2
1,21.1,Rash,15974929,2
2,21.1,Pruritus,15974929,3
0,22.0,Malignant neoplasm progression,15974932,5
0,21.1,Motor neurone disease,15974945,1
0,21.1,Dementia,15974954,6
1,21.1,Malignant neoplasm progression,15974954,6
0,21.1,Bradycardia,15974964,1
0,21.1,White blood cell count decreased,15975005,6
0,21.1,Fatigue,15975053,2
1,21.1,Alopecia,15975053,6
0,21.1,Mobility decreased,15975056,6
1,21.1,Product use in unapproved indication,15975056,6
0,21.1,Neoplasm progression,15975070,6
0,22.0,Cough,15975150,3
1,22.0,Breast discomfort,15975150,3
2,22.0,Scar,15975150,6
3,22.0,Dizziness,15975150,6
0,22.0,Neoplasm progression,15975171,6
0,21.1,Hypertension,15975320,6
1,21.1,Cardiac dysfunction,15975320,6
2,21.1,Ejection fraction decreased,15975320,6
0,21.1,Cardiac failure,15975357,5
1,21.1,Rash,15975357,6
0,21.1,Alopecia,15975374,6
1,21.1,Abdominal pain,15975374,6
2,21.1,Decreased appetite,15975374,6
3,21.1,Thrombocytopenia,15975374,6
4,21.1,Diarrhoea,15975374,6
5,21.1,Anaemia,15975374,6
6,21.1,Vomiting,15975374,6
7,21.1,Bone marrow failure,15975374,6
8,21.1,Nausea,15975374,6
0,21.1,Interstitial lung disease,15975401,6
0,21.1,Ventricular fibrillation,15975405,1
0,21.1,Rheumatoid arthritis,15975443,3
1,21.1,White blood cell count increased,15975443,6
0,21.1,Fatigue,15975530,3
1,21.1,Nausea,15975530,3
2,21.1,Hyperhidrosis,15975530,3
0,21.1,Neuropathy peripheral,15975576,3
0,22.0,Fatigue,15975584,3
1,22.0,Cough,15975584,3
2,22.0,Nausea,15975584,3
3,22.0,Pruritus,15975584,3
4,22.0,Bronchitis,15975584,3
5,22.0,Insomnia,15975584,3
6,22.0,Dyspnoea,15975584,3
7,22.0,Diarrhoea,15975584,3
8,22.0,Decreased appetite,15975584,3
9,22.0,Productive cough,15975584,3
0,21.1,Myalgia,15975667,6
1,21.1,Lung neoplasm malignant,15975667,1
2,21.1,Breast cancer,15975667,1
0,21.1,Feeling abnormal,15975680,3
1,21.1,Erythema,15975680,3
2,21.1,Unevaluable event,15975680,3
3,21.1,Abdominal pain upper,15975680,1
4,21.1,Muscle spasms,15975680,1
5,21.1,Constipation,15975680,1
6,21.1,Pancreatic carcinoma,15975680,2
7,21.1,Hypoaesthesia,15975680,3
8,21.1,Pain in extremity,15975680,3
9,21.1,Motor dysfunction,15975680,3
0,21.1,Seroma,15975710,1
1,21.1,Abdominal discomfort,15975710,1
0,22.0,Malignant neoplasm progression,15975746,5
0,22.0,Malignant neoplasm progression,15975778,5
1,22.0,Adverse event,15975778,6
0,21.1,Vomiting,15975967,1
1,21.1,Pallor,15975967,1
2,21.1,Hyperhidrosis,15975967,1
3,21.1,Pulse absent,15975967,1
4,21.1,Blood pressure decreased,15975967,1
0,21.1,Neutropenia,15975978,2
1,21.1,Hot flush,15975978,2
2,21.1,Alopecia,15975978,2
3,21.1,Neuropathy peripheral,15975978,2
4,21.1,Dry skin,15975978,2
0,21.1,Neuropathy peripheral,15976027,6
1,21.1,Ovarian cancer recurrent,15976027,6
0,22.0,Pruritus,15976072,6
0,21.1,Hypotension,15976083,2
1,21.1,Hot flush,15976083,1
2,21.1,Headache,15976083,1
3,21.1,Chills,15976083,2
4,21.1,Malaise,15976083,2
0,21.1,Staphylococcal infection,15976087,6
1,21.1,Onycholysis,15976087,1
2,21.1,Abscess limb,15976087,1
0,21.1,Alopecia,15976105,3
1,21.1,Madarosis,15976105,3
2,21.1,Hair texture abnormal,15976105,3
3,21.1,Hair colour changes,15976105,3
4,21.1,Hair disorder,15976105,3
0,21.1,Malignant neoplasm progression,15976116,6
1,21.1,Hemiparesis,15976116,1
2,21.1,Hypertension,15976116,1
3,21.1,Product supply issue,15976116,6
4,21.1,Product dose omission,15976116,6
5,21.1,Nervousness,15976116,6
6,21.1,Transient ischaemic attack,15976116,6
7,21.1,Hypotension,15976116,6
0,22.0,Full blood count decreased,15976134,6
1,22.0,White blood cell count decreased,15976134,6
0,21.1,Neoplasm progression,15976138,6
0,22.0,Epistaxis,15976162,1
1,22.0,Neutropenia,15976162,2
2,22.0,Inappropriate antidiuretic hormone secretion,15976162,6
3,22.0,Pneumonia,15976162,1
4,22.0,White blood cell count decreased,15976162,6
5,22.0,Dyspnoea,15976162,3
6,22.0,Full blood count decreased,15976162,6
0,22.1,Influenza,15976164,6
1,22.1,Off label use,15976164,6
0,22.1,Hypoacusis,15976167,6
0,22.1,Headache,15976173,6
1,22.1,Alopecia,15976173,6
2,22.1,Oral pain,15976173,6
3,22.1,Decreased appetite,15976173,6
4,22.1,Product dose omission,15976173,6
5,22.1,Anxiety,15976173,6
6,22.1,Dizziness,15976173,6
7,22.1,Irritability,15976173,6
8,22.1,Neoplasm progression,15976173,6
9,22.1,Stomatitis,15976173,6
10,22.1,Feeling abnormal,15976173,6
0,22.1,Stress,15976239,6
1,22.1,Fatigue,15976239,6
0,22.1,Hair texture abnormal,15976286,1
1,22.1,Alopecia,15976286,3
2,22.1,Hair disorder,15976286,1
3,22.1,Madarosis,15976286,3
4,22.1,Hair colour changes,15976286,1
0,22.1,Madarosis,15976295,3
1,22.1,Hair texture abnormal,15976295,3
2,22.1,Hair disorder,15976295,3
3,22.1,Alopecia,15976295,3
4,22.1,Hair colour changes,15976295,3
0,22.0,Alopecia,15976302,3
1,22.0,Hair texture abnormal,15976302,3
2,22.0,Hair disorder,15976302,3
3,22.0,Madarosis,15976302,3
4,22.0,Hair colour changes,15976302,3
0,21.1,Abdominal pain,15976303,1
1,21.1,Dyspnoea,15976303,1
2,21.1,Erythema,15976303,1
3,21.1,Flushing,15976303,1
0,22.0,Drug-induced liver injury,15976377,1
0,22.1,Fatigue,15976399,1
1,22.1,Constipation,15976399,1
2,22.1,Nausea,15976399,1
3,22.1,Liver function test abnormal,15976399,1
4,22.1,Malaise,15976399,1
5,22.1,Productive cough,15976399,1
0,21.1,Deafness,15976434,6
1,21.1,Renal impairment,15976434,2
2,21.1,Pulmonary function test decreased,15976434,6
0,21.1,Osteonecrosis,15976526,2
0,21.1,Interstitial lung disease,15976606,5
1,21.1,Gastrooesophageal reflux disease,15976606,6
0,21.1,Disease progression,15976613,5
0,22.0,Dysphagia,15976651,6
1,22.0,Malignant neoplasm progression,15976651,6
2,22.0,VIth nerve paralysis,15976651,6
3,22.0,Pain,15976651,6
4,22.0,Vision blurred,15976651,6
5,22.0,Prescribed overdose,15976651,6
6,22.0,Death,15976651,5
0,21.1,Death,15976694,5
0,21.1,Vomiting,15976698,6
1,21.1,Nausea,15976698,6
2,21.1,Anaemia,15976698,6
3,21.1,Fatigue,15976698,6
4,21.1,Bone marrow failure,15976698,6
0,21.1,Product use in unapproved indication,15976703,6
1,21.1,Malaise,15976703,6
2,21.1,Nausea,15976703,2
3,21.1,Diarrhoea,15976703,3
0,21.1,Cardiovascular disorder,15976734,6
1,21.1,Transient ischaemic attack,15976734,1
2,21.1,Epistaxis,15976734,6
3,21.1,Prostatic specific antigen increased,15976734,3
4,21.1,Diverticulum intestinal haemorrhagic,15976734,1
0,22.0,Hair colour changes,15976765,3
1,22.0,Alopecia,15976765,3
2,22.0,Hair texture abnormal,15976765,3
3,22.0,Hair disorder,15976765,3
0,21.1,Fatigue,15976767,6
0,21.1,Neoplasm progression,15976771,6
0,21.1,Madarosis,15976774,3
1,21.1,Hair texture abnormal,15976774,3
2,21.1,Hair disorder,15976774,3
3,21.1,Hair colour changes,15976774,3
4,21.1,Alopecia,15976774,3
0,22.0,Hair disorder,15976776,3
1,22.0,Alopecia,15976776,3
2,22.0,Hair colour changes,15976776,3
3,22.0,Hair texture abnormal,15976776,3
0,21.1,Flushing,15976777,2
1,21.1,Abdominal pain,15976777,2
2,21.1,Erythema,15976777,2
3,21.1,Dyspnoea,15976777,2
0,21.1,Abdominal pain upper,15976790,6
1,21.1,Haemorrhage,15976790,6
2,21.1,Muscle spasms,15976790,6
3,21.1,Malaise,15976790,6
4,21.1,Rhinitis,15976790,6
5,21.1,Fatigue,15976790,6
0,21.1,Anti-thyroid antibody positive,15976806,2
1,21.1,Fatigue,15976806,
2,21.1,Blood thyroid stimulating hormone decreased,15976806,1
3,21.1,Thyroglobulin decreased,15976806,
0,21.1,Fatigue,15976856,6
0,21.1,Sinus tachycardia,15976862,1
1,21.1,Chest pain,15976862,1
0,21.1,Injection site nodule,15976879,6
1,21.1,Injection site cellulitis,15976879,1
2,21.1,Staphylococcal infection,15976879,1
0,22.0,Malignant neoplasm progression,15976883,6
1,22.0,Metastases to lymph nodes,15976883,6
2,22.0,Metastases to lung,15976883,6
3,22.0,Metastases to soft tissue,15976883,6
4,22.0,Metastases to bone,15976883,6
5,22.0,Pleural effusion,15976883,6
6,22.0,Breast cancer,15976883,6
7,22.0,Metastases to the mediastinum,15976883,6
0,21.1,Death,15976898,5
0,22.0,Confusional state,15976982,6
0,21.1,Dermatomyositis,15976990,5
0,21.1,Plasma cell myeloma,15976991,6
0,21.1,Death,15976998,5
0,21.1,Madarosis,15977074,3
1,21.1,Hair disorder,15977074,3
2,21.1,Alopecia,15977074,3
3,21.1,Hair texture abnormal,15977074,3
4,21.1,Hair colour changes,15977074,3
0,21.1,Nipple pain,15977082,6
1,21.1,Oral candidiasis,15977082,6
2,21.1,Vulvovaginal candidiasis,15977082,6
3,21.1,Arthralgia,15977082,6
4,21.1,Osteoarthritis,15977082,6
5,21.1,Eye pain,15977082,6
6,21.1,Tooth extraction,15977082,1
7,21.1,Muscle spasms,15977082,3
8,21.1,Peripheral swelling,15977082,3
9,21.1,Sensory disturbance,15977082,3
10,21.1,Headache,15977082,6
11,21.1,Diabetes mellitus,15977082,3
12,21.1,Fatigue,15977082,3
13,21.1,Pain in extremity,15977082,6
14,21.1,Lymphoedema,15977082,3
15,21.1,Hypertension,15977082,6
16,21.1,Tooth demineralisation,15977082,3
17,21.1,Dry mouth,15977082,6
18,21.1,Osteoporosis,15977082,3
19,21.1,Toothache,15977082,6
20,21.1,Blood pressure fluctuation,15977082,3
21,21.1,Myalgia,15977082,6
22,21.1,Pain,15977082,3
23,21.1,Tooth infection,15977082,6
0,22.0,Red blood cell count decreased,15977154,1
1,22.0,Pancytopenia,15977154,1
2,22.0,Thrombocytopenia,15977154,3
3,22.0,Carbohydrate antigen 125 increased,15977154,3
4,22.0,White blood cell count decreased,15977154,6
5,22.0,Angioedema,15977154,1
6,22.0,Haemoglobin decreased,15977154,1
7,22.0,Haematocrit decreased,15977154,1
8,22.0,Thrombocytopenia,15977154,1
9,22.0,Neutrophil count decreased,15977154,6
10,22.0,Petechiae,15977154,1
0,21.1,Flushing,15977212,1
1,21.1,Dyspnoea,15977212,1
2,21.1,Infusion related reaction,15977212,1
3,21.1,Sensory level abnormal,15977212,1
0,21.1,Death,15977219,5
0,22.1,Febrile neutropenia,15977264,1
0,21.1,Malignant neoplasm progression,15977271,2
1,21.1,Breast cancer,15977271,2
0,21.1,Dehydration,15977288,6
0,22.0,Anaemia,15977341,2
1,22.0,Renal failure,15977341,2
0,22.0,Amnesia,15977342,6
1,22.0,Headache,15977342,6
2,22.0,Paraesthesia,15977342,6
3,22.0,Neuropathy peripheral,15977342,1
4,22.0,Fatigue,15977342,6
5,22.0,Hot flush,15977342,6
6,22.0,Nausea,15977342,6
7,22.0,Hypoaesthesia,15977342,6
0,22.1,Malignant neoplasm progression,15977375,5
1,22.1,Pneumothorax,15977375,1
2,22.1,Pneumonitis,15977375,2
0,21.1,Neoplasm progression,15977386,6
0,21.1,Atrial flutter,15977407,6
0,21.1,Diarrhoea,15977408,1
1,21.1,Metastases to lung,15977408,
2,21.1,Colon cancer recurrent,15977408,3
3,21.1,Palmar-plantar erythrodysaesthesia syndrome,15977408,1
0,22.1,Death,15977417,5
0,21.1,Colorectal cancer,15977421,3
0,21.1,Angiocentric lymphoma,15977427,5
1,21.1,Herpes zoster meningitis,15977427,6
2,21.1,Pneumonia,15977427,6
0,22.1,Blood pressure systolic increased,15977441,6
1,22.1,Nasopharyngitis,15977441,2
2,22.1,Carbohydrate antigen 125 increased,15977441,6
3,22.1,Product dose omission,15977441,6
0,21.1,Defaecation urgency,15977463,1
1,21.1,Wheezing,15977463,1
2,21.1,Vomiting,15977463,1
3,21.1,Loss of consciousness,15977463,1
4,21.1,Micturition urgency,15977463,1
0,21.1,Cerebrovascular accident,15977464,4
0,21.1,Cellulitis,15977471,1
1,21.1,Hypokalaemia,15977471,1
2,21.1,Fatigue,15977471,3
3,21.1,Alopecia,15977471,3
4,21.1,Pain in extremity,15977471,3
5,21.1,Ejection fraction decreased,15977471,1
0,21.1,Discomfort,15977477,6
1,21.1,Ischiorectal hernia,15977477,1
0,22.0,Interstitial lung disease,15977549,2
1,22.0,Rash,15977549,1
2,22.0,Malignant neoplasm progression,15977549,5
0,22.1,Alopecia,15977553,3
1,22.1,Hair disorder,15977553,3
2,22.1,Hair texture abnormal,15977553,3
3,22.1,Hair colour changes,15977553,3
4,22.1,Madarosis,15977553,3
0,21.1,Fall,15977585,1
1,21.1,Confusional state,15977585,1
2,21.1,Inappropriate antidiuretic hormone secretion,15977585,2
0,21.1,Urinary tract infection,15977593,3
1,21.1,Gamma-glutamyltransferase increased,15977593,3
2,21.1,Asthenia,15977593,3
3,21.1,Insomnia,15977593,3
4,21.1,Anxiety,15977593,3
5,21.1,Arthralgia,15977593,3
6,21.1,Trigger finger,15977593,1
7,21.1,Hyperhidrosis,15977593,3
8,21.1,Nausea,15977593,3
9,21.1,Mucosal dryness,15977593,3
10,21.1,Headache,15977593,3
11,21.1,Pruritus,15977593,3
12,21.1,Irritability,15977593,3
13,21.1,Weight decreased,15977593,3
14,21.1,Hot flush,15977593,3
0,22.0,Neutrophil count decreased,15977599,2
1,22.0,Malaise,15977599,3
2,22.0,Decreased appetite,15977599,3
0,22.0,Febrile neutropenia,15977611,1
0,21.1,Bone sequestrum,15977629,3
1,21.1,Exposed bone in jaw,15977629,3
2,21.1,Osteoporosis,15977629,6
3,21.1,Impaired healing,15977629,3
4,21.1,Osteonecrosis of jaw,15977629,3
0,21.1,Breast cancer,15977636,6
0,21.1,Malignant neoplasm progression,15977638,5
1,21.1,Pyrexia,15977638,1
2,21.1,Blood creatine phosphokinase increased,15977638,1
3,21.1,Non-small cell lung cancer stage IV,15977638,5
4,21.1,Musculoskeletal stiffness,15977638,6
5,21.1,Myalgia,15977638,6
0,21.1,Febrile neutropenia,15977680,6
0,21.1,Anaphylactic shock,15977733,3
0,21.1,Gingival pain,15977833,6
1,21.1,Arthropathy,15977833,6
2,21.1,Gingival bleeding,15977833,6
3,21.1,Off label use,15977833,6
0,22.0,Small intestine ulcer,15977877,1
1,22.0,Haematochezia,15977877,1
2,22.0,Erythema,15977877,6
3,22.0,Oedema,15977877,6
0,21.1,Death,15977881,5
1,21.1,Diarrhoea,15977881,6
2,21.1,Blood sodium decreased,15977881,6
3,21.1,Asthenia,15977881,6
0,22.1,Hepatitis,15977937,2
1,22.1,Cholangitis,15977937,2
0,21.1,Tumour perforation,15977961,1
1,21.1,Retroperitoneal abscess,15977961,1
2,21.1,Drug hypersensitivity,15977961,6
0,22.0,Alopecia,15978000,2
0,21.1,Alopecia,15978004,2
1,21.1,Psychological trauma,15978004,6
2,21.1,Emotional distress,15978004,6
3,21.1,Pain,15978004,6
4,21.1,Impaired quality of life,15978004,6
5,21.1,Anxiety,15978004,6
0,21.1,Anxiety,15978010,6
1,21.1,Emotional distress,15978010,6
2,21.1,Impaired quality of life,15978010,6
3,21.1,Alopecia,15978010,3
4,21.1,Pain,15978010,6
0,22.1,Emotional distress,15978012,6
1,22.1,Impaired quality of life,15978012,6
2,22.1,Anxiety,15978012,6
3,22.1,Pain,15978012,6
4,22.1,Alopecia,15978012,2
0,22.1,Alopecia,15978013,3
1,22.1,Anxiety,15978013,6
2,22.1,Impaired quality of life,15978013,6
3,22.1,Emotional distress,15978013,6
4,22.1,Pain,15978013,6
0,22.1,Alopecia,15978018,2
1,22.1,Psychological trauma,15978018,6
0,22.0,Alopecia,15978021,3
1,22.0,Psychological trauma,15978021,6
0,22.0,Alopecia,15978022,2
1,22.0,Psychological trauma,15978022,6
0,22.0,Alopecia,15978024,2
1,22.0,Impaired quality of life,15978024,6
2,22.0,Psychological trauma,15978024,6
3,22.0,Pain,15978024,6
4,22.0,Anxiety,15978024,6
5,22.0,Emotional distress,15978024,6
0,21.1,Alopecia,15978032,2
0,21.1,Alopecia,15978035,2
1,21.1,Psychological trauma,15978035,6
0,22.1,Anxiety,15978041,6
1,22.1,Pain,15978041,6
2,22.1,Alopecia,15978041,2
3,22.1,Psychological trauma,15978041,6
4,22.1,Emotional distress,15978041,6
5,22.1,Impaired quality of life,15978041,6
0,21.1,Alopecia,15978047,2
0,22.0,Alopecia,15978048,2
0,21.1,Malaise,15978146,2
1,21.1,Fall,15978146,2
2,21.1,Loss of consciousness,15978146,2
3,21.1,Back injury,15978146,2
0,22.1,Large intestine polyp,15978233,2
0,22.0,Lipase increased,15978250,2
1,22.0,Amylase increased,15978250,2
0,21.1,Death,15978349,5
0,22.0,Hepatic function abnormal,15978350,5
0,21.1,Anastomotic fistula,15978372,6
0,21.1,Bradycardia,15978388,1
0,21.1,Type 2 diabetes mellitus,15978400,6
0,22.0,Sepsis,15978439,5
1,22.0,Cardiac tamponade,15978439,3
0,21.1,Hand fracture,15978462,2
1,21.1,Palmar-plantar erythrodysaesthesia syndrome,15978462,6
2,21.1,Diarrhoea,15978462,1
3,21.1,Foot fracture,15978462,2
4,21.1,Oral pain,15978462,6
5,21.1,Dehydration,15978462,6
0,21.1,Uterine haemorrhage,15978472,6
0,21.1,Pulmonary thrombosis,15978474,1
1,21.1,Palmar-plantar erythrodysaesthesia syndrome,15978474,2
0,22.1,Listeria sepsis,15978482,2
1,22.1,Immune-mediated enterocolitis,15978482,2
